Tempest Therapeutics (TPST) Operating Margin Growth (3y) (2018)
Powered by 
Analysis
Tempest Therapeutics (TPST) Operating Margin Growth (3y) (2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | -101,581.00 |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | 4.62 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | -20,903.00 |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 179,305.00 |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | -2.53 Mn |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 123,643.00 |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 5,442.00 |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 1,354.00 |
| 10 | Tempest Therapeutics | 3.35 Mn | 2.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 950,327.00 |
| Jun 30, 2018 | 5.11 Mn |
| Mar 31, 2018 | 10.55 Mn |